Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
IPO Year: 2022
Exchange: NYSE
Website: https://www.haleon.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/16/2025 | Overweight → Equal Weight | Barclays | |
9/10/2025 | Neutral → Buy | Goldman | |
5/27/2025 | $13.40 | Neutral → Outperform | BNP Paribas Exane |
5/9/2025 | $11.25 | Equal-Weight → Overweight | Morgan Stanley |
3/5/2025 | Buy → Hold | HSBC Securities | |
1/10/2025 | Overweight → Equal-Weight | Morgan Stanley | |
1/8/2025 | Outperform → Mkt Perform | Bernstein | |
8/6/2024 | Buy → Neutral | Goldman | |
8/6/2024 | Buy | Berenberg | |
6/5/2024 | Buy | Berenberg |
Fastest customizable press release news feed in the world
Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world's #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008924109/en/A pharmacist advises a consumer on the purchase of Haleon's Otrivin nasal mist. Haleon has chosen Salesforce Life Sciences Cloud for Customer Engagement, Data Cloud, and Agentforce to support its 4,500-strong sales force globally. The AI-powered solution will enable the global cons
The taste-free, clearly dissolving prebiotic dietary fibre easily integrates into Canadians' wellness routines, helping them get their recommended daily fibre intake TORONTO, Sept. 17, 2025 /CNW/ - Benefiber, a trusted prebiotic dietary fibre that supports healthy lifestyles in Canada, is announcing a new portfolio of products that will be available in all major retailers by October 2025. Made from 100% wheat dextrin, the new Benefiber seamlessly integrates into Canadians' existing daily routines, helping them add more fibre to their diet without interrupting their busy lifestyles.
Toronto, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Say goodbye to the struggle of getting kids to take their vitamins. This fall, Emergen-C Junior Crystals brings immune support to life with a fun pop, fizz, and burst of natural fruit flavours, no water required. Now available in Canada, Emergen-C Junior Crystals bring fun to your little one's daily vitamin routine. These individually packaged crystals dissolve on the tongue with a light fizz and strawberry flavour that kids enjoy, making immune support something they'll look forward to. Formulated with 250 mg of Vitamin C, plus Zinc, B Vitamins, and Manganese, each packet is designed to help support kids immune system, energy metabolism and
The Freepod® nasal spray pump, globally used with the Otrivin® brand, is now made from 52% bio-based feedstock Aptar Pharma, a global leader in drug delivery and active material science solutions and services, is proud to announce that its Freepod® nasal spray pump - one of the delivery systems for Haleon's Otrivin® brand - is now made with mass balance bio-based resins. This is the first Aptar delivery system using such materials to be commercialized globally. The use of more sustainable renewable plastic resources is a meaningful measure to help reduce the use of fossil-based materials in healthcare primary packaging. This press release features multimedia. View the full release here:
LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care. Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi
Toronto, ON, May 26, 2025 (GLOBE NEWSWIRE) -- With National Smile Day around the corner, new research from Sensodyne, the #1 dentist-recommended brand for sensitive teeth, reveals that more than 80 per cent of Canadians want whiter teeth, but for many, sensitivity and cost are standing in the way. The recent survey in partnership with Harris Poll, showed that 40 per cent have resorted to TikTok trend alternatives like baking soda, activated charcoal and oil pulling to get the results they want, but these often come at a painful cost: nearly half (46 per cent) of users report increased sensitivity. Despite widespread awareness of dentist-administered whitening treatments, only a quart
Forager® AI Platform to Enable Haleon's Scientists to Unlock the Power of Nature for Consumer Health Haleon (LSE: HLN), a global leader in consumer health, and Brightseed, the pioneer in AI-driven discovery of bioactive compounds, announced a new collaboration to advance the discovery of plant-based, small molecules with the potential to improve human health. This partnership will leverage Brightseed's proprietary AI platform, Forager®, as a solution to accelerate scientific insights into the natural world and support Haleon's mission to deliver innovative, science-led health solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
The partnership marks Haleon Canada's first national, full-portfolio sponsorship TORONTO, April 24, 2025 /CNW/ - Canada Soccer and Haleon Canada announced a new multi-year partnership committed to promoting health and wellness on and off the pitch. As part of the deal, Haleon Canada — the makers of well-known brands like Advil, Buckley's, Centrum and Sensodyne — will serve as the Official Consumer Health partner of Canada Soccer and its Men's and Women's National Team programs. Haleon Canada, and its more than 25 brands, will have category exclusivity for Pain Relief, Oral Healthcare, Vitamins, Digestive Health, and Respiratory including cough and cold. The par
Fans can draft their top food and drink picks for a free shot at winning a share of $40,000 in total cash prizes WARREN, N.J., Jan. 9, 2025 /PRNewswire/ -- As hundreds of millions prepare to tune into the biggest day in football, a new survey from TUMS has revealed that 1 in 4 viewers will be focused on the real MVP: the food.* To celebrate gameday foodies, TUMS has teamed up with DraftKings to launch TUMS Fantasy Foodball Pool, a first-of-its-kind free online game where players can create a lineup made entirely of their favorite food and drink combinations. No matter the plate – fantasy or real – TUMS provides fast relief when occasional heartburn strikes so fans can tackle unwanted sympto
WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Barclays downgraded Haleon plc from Overweight to Equal Weight
Goldman upgraded Haleon plc from Neutral to Buy
BNP Paribas Exane upgraded Haleon plc from Neutral to Outperform and set a new price target of $13.40
Morgan Stanley upgraded Haleon plc from Equal-Weight to Overweight and set a new price target of $11.25
HSBC Securities downgraded Haleon plc from Buy to Hold
Morgan Stanley downgraded Haleon plc from Overweight to Equal-Weight
Bernstein downgraded Haleon plc from Outperform to Mkt Perform
Goldman downgraded Haleon plc from Buy to Neutral
Berenberg initiated coverage of Haleon plc with a rating of Buy
Berenberg initiated coverage of Haleon plc with a rating of Buy
Live finance-specific insights
BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (NYSE:HLN). This transaction also results in Haleon becoming a shareholder in Suave Brands Company. Suave Brands Company Chief Executive Officer, Daniel Alter, said, "As we continue to build Suave Brands Company as the top independent North American beauty & personal care company by combining the agility of a start-up with the power of market leading brands, the addition of Cha
BOSTON, Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (NYSE:HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of a now-iconic lip balm that made ChapStick a household name. For more than a century, ChapStick has added products to its portfolio with innovative new i
Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities. The exchange offers referred to herein are being made solely pursuant to the Prospectus and related documents. The exchange offers referred to herein are not being made to holders of securities in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. LONDON, Oct. 31, 2022 /PRNewswire/ -- Haleon plc ("Haleon
Live Leadership Updates
LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care. Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi
WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)